Newsbenzinga
Integra LifeSciences' $2.1B Refinancing Merits A Closer Look
· Published
Article summary
Integra LifeSciences Holdings Corporation (NASDAQ:IART) completed a $2.1 billion refinancing on October 19, 2026. Its revolving credit commitment fell $700 million, from $1.3 billion to $600 million, while the new bank
An excerpt from the original article.
Comments —
Loading comments…